000 01424 a2200385 4500
005 20250513060300.0
264 0 _c19940922
008 199409s 0 0 eng d
022 _a0001-690X
024 7 _a10.1111/j.1600-0447.1994.tb01527.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMaes, M
245 0 0 _aImmune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine.
_h[electronic resource]
260 _bActa psychiatrica Scandinavica
_cMay 1994
300 _a346-51 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAge Factors
650 0 4 _aAnalysis of Variance
650 0 4 _aClozapine
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInterleukin-6
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aReceptors, Interleukin
_xanalysis
650 0 4 _aReceptors, Interleukin-2
_xanalysis
650 0 4 _aReceptors, Interleukin-6
650 0 4 _aReference Values
650 0 4 _aSchizophrenia
_xblood
700 1 _aMeltzer, H Y
700 1 _aBosmans, E
773 0 _tActa psychiatrica Scandinavica
_gvol. 89
_gno. 5
_gp. 346-51
856 4 0 _uhttps://doi.org/10.1111/j.1600-0447.1994.tb01527.x
_zAvailable from publisher's website
999 _c8066601
_d8066601